image: Photographs (A), CT scans (B), staining (C), and microscopic images (D) of hearts from four groups of rats used in the study. The first two groups were control groups (ConNx and ConHx). The third group was treated with a compound that induces right ventricle heart failure (SuHx), which was reversed in a fourth group with administration of pioglitazone (SuHx + Pio). This material relates to a paper that appeared in the 25 April, issue of Science Translational Medicine, published by AAAS. The paper, by E. Legchenko at Hannover Medical School in Hannover, Germany, and colleagues was titled, "PPAR? agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation." view more
Credit: E. Legchenko <i>et al., Science Translational Medicine</i> (2018)